Journal metric profile

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 1.500 2025 metric year
5-Year Impact Factor 2.000 Longer citation window
JCR Quartile Q3 Subject-category quartile
JCR Category Rank 146/195 Recorded category rank

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL JCR impact factor overview

Automatically generated from the journal record shown on this page.

Page reviewed August 6, 2026

Clarivate JCR impact factor overview

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL is listed in this directory with bibliometric information for 2025. It is published by ELSEVIER SCIENCE INC. The database records a Journal Impact Factor of 1.500, presented as a Clarivate Journal Citation Reports (JCR)-based metric. Its listed JCR Impact Factor quartile is Q3.

Ranking and quartile

The recorded JCR Impact Factor category rank is 146 out of 195 journals in its listed category. A Q3 designation describes the journal’s position within its subject category; it should not be used as a direct measure of the quality of an individual article.

Citation profile

The record contains 1,016 total citations, 31 total articles, 38 citable items. The five-year Impact Factor is 2.000, which is 0.500 points above the listed standard Journal Impact Factor. These values use different citation windows and should be interpreted together rather than as a direct trend. The Journal Impact Factor without journal self-citations is recorded as 1.500. The Journal Citation Indicator is listed as 0.370.

Citation half-life

The cited half-life is recorded as 11.7 years, describing the median age of articles cited in the reporting year. The citing half-life is 7.1 years, reflecting the median age of references used by the journal’s articles.

Journal identifiers and verification

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL is identified in this record by print ISSN 0011-393X and electronic ISSN 1879-0313. Use the ISSN when checking library catalogues, publisher records, indexing databases, or the official Clarivate Journal Citation Reports entry.

Complete journal information

All values below come directly from the database record.

Journal nameCURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
Abbreviated journalCURR THER RES CLIN E
PublisherELSEVIER SCIENCE INC
Metric year2025
Overall rank10,681
ISSN0011-393X
eISSN1879-0313
Total cites1,016
Total articles31
Citable items38
Cited half-life11.7 years
Citing half-life7.1 years
JCR-based Journal Impact Factor1.500
5-Year Impact Factor2.000
Impact Factor without journal self-cites1.500
Journal Citation Indicator0.370
JCR Impact Factor quartileQ3
JCR category rank146/195
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL is 1.500 for the 2025 metric year.

What quartile is CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL?

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL is listed in quartile Q3. Quartiles describe a journal’s position within a subject category and should be interpreted within that field.

Who publishes CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL?

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL is listed as being published by ELSEVIER SCIENCE INC.

Can a JCR Journal Impact Factor be used to judge an individual article?

No. The Journal Impact Factor is a journal-level citation measure reported in Clarivate Journal Citation Reports. It does not measure the quality, reliability or influence of every individual article published by that journal.

Additional records from the same publisher or with a similar listed JCR Impact Factor.